Menu
Search
|

Menu

Close
X

Quanterix Corp QTRX.OQ (NASDAQ Stock Exchange Global Market)

23.39 USD
+1.97 (+9.20%)
As of Feb 16
chart
Previous Close 21.42
Open 21.48
Volume 40,853
3m Avg Volume --
Today’s High 23.99
Today’s Low 21.48
52 Week High 24.61
52 Week Low 15.56
Shares Outstanding (mil) 20.24
Market Capitalization (mil) 473.52
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY17
11
FY16
18
EPS (USD)
FY17
-0.753
FY16
-1.364
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
20.62
8.57
Price to Book (MRQ)
vs sector
--
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
173.01
15.12
LT Debt to Equity (MRQ)
vs sector
110.95
11.85
Return on Investment (TTM)
vs sector
--
13.54
Return on Equity (TTM)
vs sector
--
14.80

EXECUTIVE LEADERSHIP

Kevin Hrusovsky
Executive Chairman of the Board, President, Chief Executive Officer, Since 2015
Salary: $411,000.00
Bonus: $137,500.00
Joseph Driscoll
Chief Financial Officer, Since 2017
Salary: --
Bonus: --
David Duffy
Senior Vice President, Research & Development and Chief Technology Officer, Since 2013
Salary: --
Bonus: --
Ernest Orticerio
Senior Vice President - Finance and Corporate Development, Since 2017
Salary: --
Bonus: --
Mark Roskey
Senior Vice President and General Manager of Applications and Reagents, Since 2014
Salary: $236,812.00
Bonus: $82,884.00

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

113 Hartwell Ave
LEXINGTON   MA   02421-3125

Phone: +1617.3019400

Quanterix Corporation is a United States-based company, which develops tools for high definition diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. The Company offers Simoa HD-1 analyzer, which creates high density arrays of approximately 40 femtoliter microwells. Its Simoa HD-1 analyzer is an automated immunoassay platform with multiplexing and custom assay capability. The Company offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. It offers a range of complete assay kits, including multiplex panels, covering a range of therapeutic areas. Its services include Simoa Accelerator Lab and custom assay development services.

SPONSORED STORIES